B
BioPlus Co Ltd
KOSDAQ:099430
BioPlus Co Ltd
KOSDAQ:099430
Price:
5 500
KRW
-0.54%
Market Closed
Market Cap:
₩339B
Income Statement
Earnings Waterfall
BioPlus Co Ltd
BioPlus Co Ltd
Income Statement
BioPlus Co Ltd
BioPlus Co Ltd
Currency: KRW
| Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||
| Interest Expense |
58
|
195
|
352
|
498
|
521
|
452
|
332
|
200
|
13
|
58
|
33
|
25
|
60
|
114
|
159
|
219
|
263
|
357
|
377
|
0
|
|
| Revenue |
24 367
N/A
|
28 617
+17%
|
43 403
+52%
|
43 913
+1%
|
37 418
-15%
|
49 441
+32%
|
45 282
-8%
|
51 353
+13%
|
56 719
+10%
|
57 103
+1%
|
61 976
+9%
|
65 368
+5%
|
65 043
0%
|
62 248
-4%
|
54 581
-12%
|
53 479
-2%
|
66 410
+24%
|
79 779
+20%
|
89 163
+12%
|
96 802
+9%
|
|
| Gross Profit | |||||||||||||||||||||
| Cost of Revenue |
(7 802)
|
(9 322)
|
(13 499)
|
(14 161)
|
(13 772)
|
(18 312)
|
(18 329)
|
(20 716)
|
(22 913)
|
(23 189)
|
(24 896)
|
(26 418)
|
(25 470)
|
(24 542)
|
(22 355)
|
(22 076)
|
(23 767)
|
(27 722)
|
(30 072)
|
(29 849)
|
|
| Gross Profit |
16 565
N/A
|
19 295
+16%
|
29 904
+55%
|
29 753
-1%
|
23 646
-21%
|
31 130
+32%
|
26 953
-13%
|
30 637
+14%
|
33 806
+10%
|
33 914
+0%
|
37 079
+9%
|
38 951
+5%
|
39 573
+2%
|
37 705
-5%
|
32 226
-15%
|
31 403
-3%
|
42 643
+36%
|
52 057
+22%
|
59 092
+14%
|
66 953
+13%
|
|
| Operating Income | |||||||||||||||||||||
| Operating Expenses |
(4 237)
|
(4 394)
|
(6 250)
|
(6 595)
|
(5 420)
|
(8 861)
|
(8 154)
|
(8 999)
|
(8 535)
|
(8 753)
|
(9 710)
|
(10 521)
|
(11 548)
|
(12 787)
|
(13 334)
|
(15 274)
|
(18 975)
|
(23 706)
|
(31 381)
|
(39 085)
|
|
| Selling, General & Administrative |
(3 790)
|
(3 874)
|
(5 459)
|
(5 768)
|
(4 637)
|
(6 157)
|
(5 365)
|
(5 832)
|
(6 687)
|
(6 813)
|
(7 621)
|
(8 325)
|
(9 405)
|
(10 396)
|
(10 917)
|
(12 755)
|
(16 033)
|
(20 187)
|
(27 082)
|
(34 138)
|
|
| Research & Development |
(276)
|
(150)
|
(370)
|
(357)
|
(435)
|
(637)
|
(618)
|
(908)
|
(1 081)
|
(1 089)
|
(1 205)
|
(1 195)
|
(1 165)
|
(1 317)
|
(1 266)
|
(1 367)
|
(1 477)
|
(1 986)
|
(2 449)
|
(2 861)
|
|
| Depreciation & Amortization |
(171)
|
(170)
|
(222)
|
(271)
|
(348)
|
(502)
|
(606)
|
(694)
|
(768)
|
(833)
|
(895)
|
(1 012)
|
(977)
|
(1 074)
|
(1 150)
|
(1 152)
|
(1 466)
|
(1 534)
|
(1 850)
|
(2 145)
|
|
| Other Operating Expenses |
0
|
(199)
|
(199)
|
(198)
|
0
|
(1 564)
|
(1 565)
|
(1 565)
|
0
|
(18)
|
10
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
59
|
|
| Operating Income |
12 327
N/A
|
14 902
+21%
|
23 654
+59%
|
23 158
-2%
|
18 226
-21%
|
22 269
+22%
|
18 799
-16%
|
21 639
+15%
|
25 271
+17%
|
25 162
0%
|
27 369
+9%
|
28 430
+4%
|
28 026
-1%
|
24 919
-11%
|
18 892
-24%
|
16 129
-15%
|
23 667
+47%
|
28 350
+20%
|
27 710
-2%
|
27 868
+1%
|
|
| Pre-Tax Income | |||||||||||||||||||||
| Interest Income Expense |
(186)
|
(250)
|
(476)
|
(4 476)
|
(2 362)
|
(2 243)
|
(1 396)
|
3 390
|
3 043
|
3 926
|
3 589
|
3 710
|
3 764
|
3 697
|
7 719
|
6 918
|
(4 161)
|
(4 770)
|
(7 319)
|
(6 820)
|
|
| Non-Reccuring Items |
0
|
0
|
1
|
0
|
(1 564)
|
0
|
0
|
0
|
(28)
|
0
|
(19)
|
(19)
|
9
|
9
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
(3)
|
0
|
0
|
0
|
0
|
18
|
(9)
|
(109)
|
(81)
|
0
|
(78)
|
23
|
(9)
|
(9)
|
480
|
480
|
593
|
593
|
109
|
109
|
|
| Total Other Income |
(4)
|
(44)
|
(91)
|
(102)
|
(133)
|
(153)
|
(419)
|
(678)
|
(734)
|
(827)
|
585
|
850
|
950
|
963
|
(668)
|
(768)
|
(2 436)
|
(2 449)
|
(1 430)
|
(1 247)
|
|
| Pre-Tax Income |
12 134
N/A
|
14 608
+20%
|
23 088
+58%
|
18 579
-20%
|
14 168
-24%
|
19 892
+40%
|
16 976
-15%
|
24 241
+43%
|
27 471
+13%
|
28 261
+3%
|
31 446
+11%
|
32 994
+5%
|
32 740
-1%
|
29 579
-10%
|
26 424
-11%
|
22 759
-14%
|
17 664
-22%
|
21 724
+23%
|
19 070
-12%
|
19 910
+4%
|
|
| Net Income | |||||||||||||||||||||
| Tax Provision |
(2 431)
|
(2 910)
|
(3 943)
|
(4 297)
|
(3 495)
|
(4 803)
|
(4 979)
|
(6 172)
|
(6 763)
|
(6 003)
|
(6 722)
|
(6 813)
|
(5 318)
|
(5 472)
|
(3 856)
|
(2 667)
|
(153)
|
1 658
|
1 510
|
952
|
|
| Income from Continuing Operations |
9 703
|
11 698
|
19 146
|
14 283
|
10 673
|
15 088
|
11 997
|
18 069
|
20 708
|
22 258
|
24 723
|
26 181
|
27 422
|
24 107
|
22 568
|
20 092
|
17 510
|
23 382
|
20 580
|
20 862
|
|
| Income to Minority Interest |
0
|
(0)
|
(0)
|
1
|
0
|
92
|
169
|
274
|
429
|
410
|
(87)
|
(1 301)
|
(1 841)
|
(2 324)
|
(2 555)
|
(2 293)
|
(3 359)
|
(3 778)
|
(4 371)
|
(4 812)
|
|
| Net Income (Common) |
9 703
N/A
|
11 698
+21%
|
19 146
+64%
|
14 284
-25%
|
10 673
-25%
|
15 180
+42%
|
12 165
-20%
|
18 343
+51%
|
21 137
+15%
|
22 668
+7%
|
24 636
+9%
|
24 880
+1%
|
25 581
+3%
|
21 783
-15%
|
20 013
-8%
|
17 799
-11%
|
14 151
-20%
|
19 604
+39%
|
16 209
-17%
|
16 049
-1%
|
|
| EPS (Diluted) |
174.38
N/A
|
840.96
+382%
|
1 516.51
+80%
|
281.25
-81%
|
206.02
-27%
|
293.24
+42%
|
216.39
-26%
|
319.79
+48%
|
368.51
+15%
|
373.48
+1%
|
407.3
+9%
|
415.01
+2%
|
422.18
+2%
|
361.55
-14%
|
332.22
-8%
|
297.4
-10%
|
234.21
-21%
|
288.15
+23%
|
238.43
-17%
|
271.28
+14%
|
|
Switch to:
Switch to:
See Also
Discover More
